Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
Oxford Finance: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
Oxford Finance
Oxford Finance
Active
Website
LinkedIn
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 2, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Oxford Finance.
JA
J. Alden Philbrick
President & Chief Executive Officer
MM
Mark Matheson
EVP Chief Credit Officer
JN
John N. Toufanian
Senior Counsel
TA
Timothy A. Lex
Chief Operating Officer & Executive Vice President
AS
Austin Szafranski
N/A
CH
Colette Hastings Featherly
Senior Vice President
DJ
Darren J. Margulis
Senior Director, Credit & Portfolio Management
GH
Garrett Henn
Managing Director, Head of Life Sciences Credit - West
Leadership Team
Key people at Oxford Finance.
JA
J. Alden Philbrick
President & Chief Executive Officer
MM
Mark Matheson
EVP Chief Credit Officer
John N. Toufanian
Senior Counsel
TA
Timothy A. Lex
Chief Operating Officer & Executive Vice President
AS
Austin Szafranski
N/A
Colette Hastings Featherly
Senior Vice President
DJ
Darren J. Margulis
Senior Director, Credit & Portfolio Management
GH
Garrett Henn
Managing Director, Head of Life Sciences Credit - West
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Jan 28, 2026
Sokin
$100.0M Debt
Austin Szafranski
—
Nov 15, 2022
Renibus Therapeutics
$33.0M Debt / Other Equity
—
—
Jul 6, 2022
RefleXion Medical
$125.0M Debt
Christopher Herr
—
Jun 1, 2022
SeLux Diagnostics
$30.0M Debt
Christopher Herr
—
Feb 15, 2022
OncoResponse
$50.0M Debt
Christopher Herr
—
Nov 9, 2021
Platelet BioGenesis
$20.0M Debt
Christopher Herr
—
Nov 5, 2021
Viracta Therapeutics
$50.0M Debt
Oxford Finance
, Silicon Valley Bank
—
Jul 7, 2021
Impel Pharmaceuticals
$50.0M Debt
Christopher Herr
, Silicon Valley Bank
—
Jan 13, 2021
Immunocore
$175.0M Debt / Series C
BlackRock
—
Dec 8, 2020
Nature's Fynd
$45.0M Debt
Oxford Finance
,
Trinity Capital
—
Feb 7, 2020
Genapsys
$75.0M Other Equity
Oxford Finance
—
Sep 9, 2019
Codex DNA
$25.0M Series A
Northpond Ventures
BroadOak Capital Partners
Aug 8, 2019
ObsEva
$75.0M Debt
Christopher Herr
—
May 1, 2019
RefleXion Medical
$60.0M Debt
Oxford Finance
—
Jan 29, 2019
AliveCor
$20.0M Debt
Oxford Finance
—
Nov 29, 2018
Karius
$25.0M Debt
Christopher Herr
—
Mar 8, 2018
Xeris Biopharma
$55.0M Debt / Series C
Daniel Fero
,
Oxford Finance
, Silicon Valley Bank
Wild Basin Investments
Apr 19, 2017
Cerapedics
$20.0M Debt
Oxford Finance
—
Aug 30, 2016
Bi02 Medical
$3.0M Debt
Oxford Finance
—
Aug 9, 2016
CVRx
$77.7M Debt / Series G
Johnson & Johnson Innovation
Action Potential Venture Capital
,
New Enterprise Associates
,
Windham Venture Partners
, Ysios BioFund I
Jun 29, 2016
Monteris Medical
$10.0M Debt
Oxford Finance
—
Jan 7, 2016
Bi02 Medical
$14.0M Debt / Series D
—
—
May 13, 2015
Labcyte
$17.0M Debt
Oxford Finance
, Silicon Valley Bank
—
May 13, 2015
Juventas Therapeutics
$13.5M Debt / Series B
Green Cross Holdings
,
POSCO Technology Investment
—
Apr 22, 2015
ReShape Medical
$12.0M Debt
—
Christopher Herr
, Brett Maver
Show all 26 investments (+1 more)